JUAN MARÍA DE LA
OBRA SIERRA
Chercheur dans le période 1988-2015
Eduardo
Tolosa Sarró
Publications dans lesquelles il/elle collabore avec Eduardo Tolosa Sarró (16)
2023
-
Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
npj Parkinson's Disease, Vol. 9, Núm. 1
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
-
Identification of sixteen novel candidate genes for late onset Parkinson’s disease
Molecular Neurodegeneration, Vol. 16, Núm. 1
-
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease
Annals of Neurology, Vol. 90, Núm. 1, pp. 35-42
2020
-
Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders
Brain, Vol. 143, Núm. 9, pp. 2771-2787
-
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications, Vol. 11, Núm. 1
2019
-
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet Neurology, Vol. 18, Núm. 12, pp. 1091-1102
-
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
npj Parkinson's Disease, Vol. 5, Núm. 1
-
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
npj Parkinson's Disease, Vol. 5, Núm. 1
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
-
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
Movement Disorders, Vol. 34, Núm. 4, pp. 460-468
2018
-
LRP10 in α-synucleinopathies
The Lancet Neurology
-
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain
Movement Disorders, Vol. 33, Núm. 4, pp. 637-641
2014
-
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
PLoS ONE, Vol. 9, Núm. 10